QUALITY OF LIFE, SYMPTOMS OF ANXIETY AND DEPRESSION, AND REHABILITATION NEEDS OF PEOPLE RECEIVING CHEMOTHERAPY FOR CANCER AT THE INITIATION OF CHEMOTHERAPY AND THREE MONTHS LATER.

2.50
Hdl Handle:
http://hdl.handle.net/10755/165157
Category:
Abstract
Type:
Presentation
Title:
QUALITY OF LIFE, SYMPTOMS OF ANXIETY AND DEPRESSION, AND REHABILITATION NEEDS OF PEOPLE RECEIVING CHEMOTHERAPY FOR CANCER AT THE INITIATION OF CHEMOTHERAPY AND THREE MONTHS LATER.
Author(s):
Saevarsdottir, Thorunn; Fridriksdottir, Nanna; Gunnarsdottir,Sigridur
Author Details:
Thorunn Saevarsdottir, RN, MS, Transplant coordinator, Landspitali University Hospital, Hringbraut, Reykjavik, Iceland, email: torunnsa@landspitali.is; Nanna Fridriksdottir; Sigridur Gunnarsdottir
Abstract:
Topic: The diagnosis and treatment of cancer is known to affect quality of life (QOL). Therefore, QOL has become an important focus of both oncology nursing practice and research. Purpose: To describe QOL, symptoms of anxiety and depression and rehabilitation needs, over time, in a group of Icelandic cancer patients receiving chemotherapy. Framework: The study focuses on the five QOL dimensions measured with the CARES-SF- Physical, psychosocial, marital, sexual and medical interaction dimensions-, as well as on symptoms of anxiety and depression. Methods: The study is prospective, descriptive and longitudinal. The sample is a convenience sample of cancer patients initiating chemotherapy protocol for newly diagnosed, progressive or relapsing cancer. Participants completed the Icelandic version of CARES-SF (Cancer Rehabilitation Evaluation System, Short Form), HADS (Hospital Anxiety and Depression Scale), and a short demographic questionnaire at the initiation of chemotherapy (T1) and three months later (T2). Data analyses were performed with SPSS version 11.0 for Windows, using descriptive statistics and inferential statistics. Significance level was set at p < 0.05. Findings: QOL measured with the CARES-SF was significantly poorer three months after initiation of chemotherapy. QOL was poorest in the sexual and the physical dimensions, at both time points. Demographic and disease variables were not significantly related to QOL, with the exception of age. Older people experienced better QOL. Significantly more participants had scores suggesting symptoms of depression on the HAD-D scale at time 2. Symptoms of anxiety and depression were negatively correlated with quality of life. The participants had an average of 3.3 (5) rehabilitation needs at the initiation of chemotherapy, and 2.97 (5.7) after three months, (range 1-25 and 1-29 needs per patient respectively). The difference was not significant. QOL of people receiving chemotherapy for cancer is affected over time. Those participants who experienced symptoms of anxiety or depression experienced significantly poorer QOL. Nurses need to be attentive to changes in their patients QOL and particularly of issues concerning physical and sexual health. Patients receiving chemotherapy should have QOL assessment performed on a regular basis.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2006
Conference Name:
31st Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Boston, Massachusetts, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleQUALITY OF LIFE, SYMPTOMS OF ANXIETY AND DEPRESSION, AND REHABILITATION NEEDS OF PEOPLE RECEIVING CHEMOTHERAPY FOR CANCER AT THE INITIATION OF CHEMOTHERAPY AND THREE MONTHS LATER.en_GB
dc.contributor.authorSaevarsdottir, Thorunnen_US
dc.contributor.authorFridriksdottir, Nannaen_US
dc.contributor.authorGunnarsdottir,Sigriduren_US
dc.author.detailsThorunn Saevarsdottir, RN, MS, Transplant coordinator, Landspitali University Hospital, Hringbraut, Reykjavik, Iceland, email: torunnsa@landspitali.is; Nanna Fridriksdottir; Sigridur Gunnarsdottiren_US
dc.identifier.urihttp://hdl.handle.net/10755/165157-
dc.description.abstractTopic: The diagnosis and treatment of cancer is known to affect quality of life (QOL). Therefore, QOL has become an important focus of both oncology nursing practice and research. Purpose: To describe QOL, symptoms of anxiety and depression and rehabilitation needs, over time, in a group of Icelandic cancer patients receiving chemotherapy. Framework: The study focuses on the five QOL dimensions measured with the CARES-SF- Physical, psychosocial, marital, sexual and medical interaction dimensions-, as well as on symptoms of anxiety and depression. Methods: The study is prospective, descriptive and longitudinal. The sample is a convenience sample of cancer patients initiating chemotherapy protocol for newly diagnosed, progressive or relapsing cancer. Participants completed the Icelandic version of CARES-SF (Cancer Rehabilitation Evaluation System, Short Form), HADS (Hospital Anxiety and Depression Scale), and a short demographic questionnaire at the initiation of chemotherapy (T1) and three months later (T2). Data analyses were performed with SPSS version 11.0 for Windows, using descriptive statistics and inferential statistics. Significance level was set at p &lt; 0.05. Findings: QOL measured with the CARES-SF was significantly poorer three months after initiation of chemotherapy. QOL was poorest in the sexual and the physical dimensions, at both time points. Demographic and disease variables were not significantly related to QOL, with the exception of age. Older people experienced better QOL. Significantly more participants had scores suggesting symptoms of depression on the HAD-D scale at time 2. Symptoms of anxiety and depression were negatively correlated with quality of life. The participants had an average of 3.3 (5) rehabilitation needs at the initiation of chemotherapy, and 2.97 (5.7) after three months, (range 1-25 and 1-29 needs per patient respectively). The difference was not significant. QOL of people receiving chemotherapy for cancer is affected over time. Those participants who experienced symptoms of anxiety or depression experienced significantly poorer QOL. Nurses need to be attentive to changes in their patients QOL and particularly of issues concerning physical and sexual health. Patients receiving chemotherapy should have QOL assessment performed on a regular basis.en_GB
dc.date.available2011-10-27T12:13:32Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:13:32Z-
dc.conference.date2006en_US
dc.conference.name31st Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationBoston, Massachusetts, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.